Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20260330002Phase 2Completed
A Phase 2 trial of dexmedetomidine, midazolam in Emergence agitation (EA), sponsored by Chatchayapa Rathanasutthajohn, MD. Started Apr 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20260330002.